CardioDex Company

CardioDex Ltd. develops, manufactures, and markets a disposable solution for the closure of arterial access sites following endovascular catheterization procedures. It offers a disposable closure device that does not use glue, collagen, suturing, and other foreign materials that promote a clinical reaction and thus no residual material is deposited in the patient’s body. The company’s products allow cardiologists, radiologists, cath-labs, and patients to overcome the limitations confronted by them. Its products are used in diagnostic and therapeutic markets. CardioDex's products expedite arterial closure through hemostasis.
Technology: Biotechnology
Industry: Preventive Medicine
Headquarters: Caesarea, Israel
Founded Date: 2004
Employees Number: 50-200
Funding Status: N/A

Visit Website
info@cardiodx.com
twitter.com/cardiodx
Register and Claim Ownership